FDA Approves Stronger Wegovy for Weight Loss

0:00It's March 19, here's your global news in two minutes. Federal regulators have approved a stronger version of the Obesity Drug, WEGOV. The new weekly injection delivers 7.2 mg of semi-glutide, doubling the previous top dose of 2.4 mg from NOVO. NorDesk. This approval came through the FDA's Fast Track Review, just 54 days after submission. The higher dose will reach US pharmacies in April, though pricing details are still pending. Europe already okayed the same upgrade back in February. It targets patients who tolerate the lower dose, but fall short of their weight loss goals, based on recent medical studies. Experts like Harvard endocrinologist Jodie Duchet see it as a big help for those with limited results on WEGOV or rival drugs. She calls the dose jumps substantial and urges monitoring real-world side effects. The FDA also greenlit an ORA WEGOV pill in December, packing 25 mg for better gut absorption.

1:02This expands options as demand for these treatments surges. The Daily News Now is powered by our sponsor, link in the description. Comfort you can hear. Sound you can relax into, S-O-L-L-I, solelypillow.com.